July
1
Transformation of the CAR-T patent landscape
It’s 30 years since Zelig Eshhar and colleagues at the Weizmann Institute of Science in Israel first described chimeric antigen receptors (CARs). But only over the last decade has biomedical research really focused on the potential of CAR-T cells to create medicines. This is clearly shown in the graph below …
Read More